Related Experiment Video
Updated: Mar 11, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Complete revascularization versus culprit-only revascularization in ST-segment elevation myocardial infarction and
Chong-Hui Wang1, Shu-Yang Zhang1, Xiao-Feng Jin1
1Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Insights
Complete revascularization (CR) is superior to culprit-only revascularization (COR) for ST-segment elevation myocardial infarction (STEMI) patients with multivessel disease. CR significantly reduces major adverse cardiac events and repeat revascularization, offering better patient outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Research
Background:
- ST-segment elevation myocardial infarction (STEMI) with multivessel disease presents complex treatment challenges.
- Percutaneous coronary intervention (PCI) strategies include complete revascularization (CR) and culprit-only revascularization (COR).
- The optimal PCI strategy for STEMI patients with multivessel disease remains debated.
Purpose of the Study:
- To compare the clinical outcomes of CR versus COR in patients with STEMI and multivessel disease undergoing primary PCI.
- To determine the more appropriate revascularization strategy based on meta-analysis of randomized controlled trials (RCTs).
Main Methods:
- A meta-analysis of published RCTs was conducted, searching PubMed, EMBASE, and CENTRAL databases.
- Eight RCTs involving 2060 patients (1080 CR, 980 COR) with a follow-up of 6-38 months were included.
- Trial sequential analysis was performed to assess the robustness of the findings.
Main Results:
- Overall, CR significantly reduced major adverse cardiac events (MACE) and repeat revascularization compared to COR.
- Immediate CR (ICR) further reduced MACE, all-cause death/MI, non-fatal MI, and repeat revascularization versus COR.
- Staged CR (SCR) only showed a significant reduction in MACE compared to COR.
- No significant differences were observed in contrast-induced nephropathy, major hemorrhage, or stroke between CR and COR.
- Trial sequential analysis confirmed firm evidence for MACE and revascularization benefits with CR in the overall population and ICR subgroup.
Conclusions:
- Complete revascularization (CR) is a preferable strategy to culprit-only revascularization (COR) in STEMI patients with multivessel disease undergoing primary PCI.
- CR, particularly immediate CR, offers significant benefits in reducing adverse cardiac events and the need for repeat procedures.
- The safety profile regarding complications like nephropathy and hemorrhage is comparable between CR and COR.
Abstract:
The present study compared the outcomes of complete revascularization (CR) and culprit-only revascularization (COR) performed during primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease through a meta-analysis in order to determine which strategy is more appropriate. Published randomized controlled trials (RCTs) were retrieved from the PubMed, EMBASE, and CENTRAL databases. Eight RCTs with 2060 patients were selected (1080 patients underwent CR [immediate (ICR) or staged (SCR)] and 980 patients underwent COR). The follow-up was 6-38months. In the overall population, CR reduced major adverse cardiac events (MACE) and repeat revascularization when compared to those with COR (RR 0.60, 95% CI 0.50-0.72; RR 0.49, 95% CI 0.33-0.73). In the subgroups analysis, ICR reduced MACE, all-cause death and/or MI, non-fatal MI, and repeat revascularization compared to COR (RR 0.44, 95% CI 0.32-0.60; RR 0.55, 95% CI 0.36-0.85; RR 0.35, 95% CI 0.17-0.71; RR 0.35, 95% CI 0.24-0.52; SCR reduced only MACE when compared with those in COR (RR 0.71, 95% CI 0.56-0.89). However, trial sequential analysis powered for a 25% relative reduction indicated firm evidence (cumulative z-curve crossed the monitoring boundary) for only MACE and revascularization in the overall population and ICR subgroup. Contrast-induced nephropathy, major hemorrhage, and stroke incidences were not different between CR and COR. Based on these findings, we believe that CR is preferable to COR in STEMI and multivessel disease patients undergoing primary PCI.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview

